Weekly Recap | Asymchem -9.35%, starts first buyback

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Week

Asymchem fell 9.35% this week to close at HK$103.70, underperforming the Hang Seng Index by roughly 3.7 percentage points. The week’s range was wide at 13.57%, with a clear fade after the open: Monday gapped higher and printed a high of HK$117.50 before settling at HK$115.00; selling then took over through Thursday, when the stock hit a low of HK$102.30 and closed near the bottom of the range. Average daily volume came in at 474,069 shares, about a third below the median level.

Key Events

The main company-specific development was the announcement of its first share repurchase, disclosed after Wednesday’s close. That was followed on Friday by a HKEX next-day disclosure return from Asymchem Laboratories Tianjin confirming the buyback had been executed. Two other next-day disclosure returns during the week related to separate entities and are not treated as part of the Asymchem story. The takeaway is that the company initiated its first buyback since listing, with the signal outweighing the size of any single transaction.

Analyst Ratings

Among the 8 brokers covering Asymchem, 4 rate it buy, 3 rate it overweight, and 1 rates it hold, with no underweight or sell ratings. The consensus rating is buy, with a consensus target of HK$154.18, about 48.7% above the current price. The target range runs from HK$127.78 to HK$180.28, a wide spread that points to differing views on the pace of profit recovery. Within the pharmaceutical sector, Asymchem ranks 9th out of 29 names.

The Week Ahead

No company-specific events fall directly in the coming week. The next major item is the FY2026 annual results, scheduled for after market close on 1 April 2027, with consensus estimates of HK$4.4687 EPS and HK$9.492 billion in revenue, both up around 28% year on year. In the near term, the watch points are the pace of buyback execution, whether the stock can stabilise around its 20-day moving average, and whether the Hang Seng Index’s directional repair continues.

In Short

This week’s price decline sits in tension with the company’s first buyback and a consensus rating that remains buy. Valuation is not at extreme lows, with a P/E of 27.2x and P/B of 1.81x. The latest session’s fund flow shows large and medium orders as net sellers, with small orders net buyers but in smaller size, leaving the direction choppy. What matters next is whether buybacks persist, whether average daily volume recovers above the median, and whether the stock can break out of the HK$102-117 band with conviction.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.